PeptidePROTACs The field of drug development is continuously seeking innovative approaches to target diseases with greater precision and efficacy. Among the most promising advancements is the emergence of protac peptide technology, a novel strategy that leverages the power of peptides to induce targeted protein degradation. This innovative modality offers significant advantages over traditional therapeutic methods, opening new avenues for treating a wide range of conditions作者:J Jin·2020·被引用次数:138—The booming p-PROTAC technologyoffers superior advantages over traditional peptide drugswith auxiliary action mechanism and synergetic therapeutic effect. It ....
PROTAC peptides, a specific class within this burgeoning field, are designed to hijack the cell's natural protein disposal system, the ubiquitin-proteasome pathway. Unlike conventional drugs that inhibit protein function, peptide-based PROTACs act as molecular matchmakers, bringing a target protein of interest (POI) into close proximity with an E3 ubiquitin ligase. This proximity taggs the POI with ubiquitin, marking it for destruction by the proteasomeA PROTAC peptide induces durable β-catenin degradation .... This mechanism allows for the *degradation* of proteins, rather than just their inhibition, offering a more profound and potentially durable therapeutic effect.
The advantages offered by peptide PROTAC drugs are numerous. Their inherent biodegradability and low toxicity, coupled with flexibility in structural design, make them attractive candidates for therapeutic development. Furthermore, the ability of peptide-based PROTACs to target a broader range of proteins, including those previously considered undruggable by small molecules, is a significant breakthrough2020年9月5日—PROTAC is a new type of treatmentthat can induce the dynamic degradation of intracellular or nuclear protein of interest (POI), and and it plays a significant .... Researchers are exploring how peptide PROTACs can be utilized for various therapeutic applications, including cancer treatment and the management of other diseases characterized by aberrant protein accumulation.
Recent research highlights the impressive capabilities of protac peptide technologyAdvances in Peptide-Based Chimeric Strategies for Targeted .... For instance, studies have shown that Nano-PROTACs can significantly inhibit tumor growth in preclinical models, exhibiting dose-dependent antitumor effects. This suggests a promising future for these engineered molecules in oncology. In one notable study, a PROTAC peptide was developed to induce the degradation of β-catenin, a key protein involved in Wnt signaling. This approach successfully blocked Wnt signaling, demonstrating the potential of PROTAC peptides to precisely target and disrupt disease-driving pathways.2025年12月3日—(28) In A549 and LNCap xenograft mouse models,Nano-PROTACs significantly inhibit tumor growth, exhibiting dose-dependent antitumor effects.
Another significant development is the creation of a fully peptide-based PROTAC, designated FPP29. This novel molecule has shown strong toxicity and inhibitory effects, underscoring the potential for highly potent and specific degradation of target proteins. Furthermore, a peptide-based PROTAC known as BPD has been shown to effectively degrade BRCA2, a protein crucial for DNA repair. By selectively accumulating in tumor cells and reducing homologous recombination, BPD offers a targeted approach to sensitize cancer cells to treatment.A Peptide-Based PROTAC Degrader of BRCA2 Sensitizes ...
The peptide PROTAC modality, particularly when utilizing peptide components, offers superior advantages over traditional peptide drugs.2025年12月3日—(28) In A549 and LNCap xenograft mouse models,Nano-PROTACs significantly inhibit tumor growth, exhibiting dose-dependent antitumor effects. The auxiliary action mechanism and synergetic therapeutic effect provided by this approach are key to its growing appeal. The potential for multitargeting, an inherent characteristic of some peptide-based PROTACs, further expands their therapeutic utility, allowing for the simultaneous targeting of multiple disease-related proteins.Peptide PROTAC in Drug Development As the technology matures, we can anticipate a broader application of peptide PROTAC in drug development, addressing unmet medical needs across various therapeutic areas.作者:J Jin·2020·被引用次数:138—The booming p-PROTAC technologyoffers superior advantages over traditional peptide drugswith auxiliary action mechanism and synergetic therapeutic effect. It ... The continuous exploration and refinement of peptide PROTAC design and application are poised to revolutionize how we approach disease treatment.作者:J Jin·2020·被引用次数:138—The booming p-PROTAC technologyoffers superior advantages over traditional peptide drugswith auxiliary action mechanism and synergetic therapeutic effect. It ...
Join the newsletter to receive news, updates, new products and freebies in your inbox.